RBC Capital analyst Arun Viswanathan maintained a Buy rating on Chemours Company (CC – Research Report) on January 26 and set a price target of $44.00. The company’s shares closed last Thursday at $32.57.
According to TipRanks.com, Viswanathan is a 5-star analyst with an average return of 9.5% and a 63.9% success rate. Viswanathan covers the Basic Materials sector, focusing on stocks such as Sherwin-Williams Company, Axalta Coating Systems, and Berry Global Group.
Currently, the analyst consensus on Chemours Company is a Moderate Buy with an average price target of $43.29.
Based on Chemours Company’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $1.68 billion and net profit of $214 million. In comparison, last year the company earned revenue of $1.23 billion and had a net profit of $76 million.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
The Chemours Co. is a holding company, which engages in the provision of performance chemicals. It operates through the following segments: Titanium Technologies, Fluoroproducts and Chemical Solutions. The Titanium Technologies segment produces titanium dioxide. The Fluoroproducts segment supplies refrigerants and industrial fluoropolymer resins. The Chemical Solutions segment provides chemicals used in gold production, oil refining, agriculture, and industrial polymers. The firm offers refrigerants, industrial fluoropolymer resins, sodium cyanide, performance chemicals and intermediates, and titanium dioxide pigments to the plastics and coatings, refrigeration and air conditioning, general industrial, electronics, mining, and oil refining markets. The company was founded on February 18, 2014 and is headquartered in Wilmington, Delaware.
Read More on CC: